Key statistics
On Monday, Profound Medical Corp (PROF:NAQ) closed at 6.50, -27.37% below its 52-week high of 8.95, set on Jan 13, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 6.48 |
|---|---|
| High | 6.73 |
| Low | 6.27 |
| Bid | 5.00 |
| Offer | 7.35 |
| Previous close | 6.49 |
| Average volume | 177.68k |
|---|---|
| Shares outstanding | 36.29m |
| Free float | 32.17m |
| P/E (TTM) | -- |
| Market cap | 317.58m CAD |
| EPS (TTM) | -1.83 CAD |
Data delayed at least 15 minutes, as of Feb 09 2026 21:00 GMT.
More ▼
- PRO FAMILIA and Profound Medical Celebrate 500 Sonalleve® Procedures, Expanding Access to Incision-Free Care for Women’s Health
- Profound Medical Announces Upcoming Investor Events
- Mount Sinai Becomes First in Metro New York to Deliver Incision-Free, MRI-Guided Prostate Treatment with TULSA-PRO®
- Profound Surpasses 2025 TULSA-PRO® Installed Base Goal
- Johns Hopkins Medicine Treats First Commercial TULSA-PRO® Case
- Profound Medical Corp. Announces Closing of Private Placement
- Profound Medical Corp. Announces Upsize of Private Placement
- Profound Medical Corp. Closes $36 Million Registered Direct Offering; Expects to Complete Subsequent Private Placement On or Before December 30th
- Profound Medical Corp. Announces Pricing of up to $40 Million Financing Comprised of a $36 Million Registered Direct Offering and a Subsequent $4 Million Private Placement
- Stanford Medicine’s Dr. Pejman Ghanouni Receives RSNA’s Cum Laude Award for CAPTAIN Perioperative Data Presentation
More ▼
